Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced new data that will be ...

Crinetics will also present three abstracts from its atumelnant clinical development program, including an oral presentation of Phase 2 trial results in congenital adrenal hyperplasia (CAH).

SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced eight abstracts from its novel clinical development programs, including oral presentations ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

A budget impact model from BUPA, a multinational health insurance provider with over 60 million customers, will outline a 43% expected reduction in healthcare costs using Signatera-guided adjuvant ...

SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced eight abstracts from its novel clinical development programs, including oral presentations ...

Best By Wayne Williams last updated 1 July 2025 If you're after the best projector for your business, here's our round-up of top picks at the most affordable prices ...

Individual presentation times are noted in your formal invitation and on the Speaker Center website. A question-and-answer panel will be held for all session participants at the end of the ...

📰 News 2025 Jun 24: Paper got selected for Oral presentation. Out of more than 3,000 accepted papers, only 243 were selected for oral presentations. 2025 Jun 8: We released our generated video data ...